NATERA, INC. Increase (Decrease) in Other Operating Assets
NATERA, INC. (NTRA) reported Increase (Decrease) in Other Operating Assets of $6.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2023-03-01
- NATERA, INC. increase (decrease) in other operating assets for the quarter ending 2022-12-31 was -$194.00K, a 108.14% decline year-over-year.
- NATERA, INC. increase (decrease) in other operating assets for the quarter ending 2021-12-31 was $2.38M, a 1417.83% increase year-over-year.
- NATERA, INC. increase (decrease) in other operating assets for the quarter ending 2021-09-30 was $527.00K, a 26250.00% increase year-over-year.
- NATERA, INC. increase (decrease) in other operating assets for the quarter ending 2020-12-31 was $157.00K.
- NATERA, INC. increase (decrease) in other operating assets for fiscal 2022 was $6.00K, a 99.80% decline from fiscal 2021.
- NATERA, INC. increase (decrease) in other operating assets for fiscal 2021 was $2.93M, a 4788.33% increase from fiscal 2020.
- NATERA, INC. increase (decrease) in other operating assets for fiscal 2020 was $60.00K, a 99.34% decline from fiscal 2019.
- NATERA, INC. increase (decrease) in other operating assets for fiscal 2019 was $9.10M.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$194.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $6.00K 10-K · filed 2023-03-01 | ||
| 2022-09-30 | $200.00K 10-Q · filed 2022-11-09 | |||
| 2021-12-31 | $2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $2.91M derived: sum of 2 quarters · filed 2023-03-01 | $2.93M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $527.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $550.00K 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | $23.00K 10-Q · filed 2021-08-06 | |||
| 2020-12-31 | $157.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $159.00K derived: sum of 2 quarters · filed 2023-03-01 | $159.00K derived: sum of 3 quarters · filed 2023-03-01 | $60.00K 10-K · filed 2023-03-01 |
| 2020-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $2.00K derived: sum of 2 quarters · filed 2021-11-05 | -$97.00K 10-Q · filed 2021-11-05 | -$297.00K derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$99.00K 10-Q · filed 2021-08-06 | -$299.00K derived: sum of 3 quarters · filed 2022-02-25 | $9.00M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | -$99.00K 10-Q · filed 2021-05-07 | -$299.00K derived: sum of 2 quarters · filed 2022-02-25 | $9.00M derived: sum of 3 quarters · filed 2022-02-25 | $18.50M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $9.10M derived: sum of 2 quarters · filed 2022-02-25 | $18.60M derived: sum of 3 quarters · filed 2022-02-25 | $9.10M 10-K · filed 2022-02-25 |
| 2019-09-30 | $9.30M 10-Q · filed 2020-11-06 | $18.80M derived: sum of 2 quarters · filed 2020-11-06 | $9.30M 10-Q · filed 2019-11-08 | $18.56M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $9.50M 10-Q · filed 2020-08-07 | $9.50M 10-Q · filed 2019-08-09 | $9.27M derived: sum of 3 quarters · filed 2021-02-26 | $9.38M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | -$201.00K 10-Q · filed 2020-05-08 | -$234.00K derived: sum of 2 quarters · filed 2021-02-26 | -$121.00K derived: sum of 3 quarters · filed 2021-02-26 | -$321.00K derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | -$33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $80.00K derived: sum of 2 quarters · filed 2021-02-26 | -$120.00K derived: sum of 3 quarters · filed 2021-02-26 | -$335.00K 10-K · filed 2021-02-26 |
| 2018-09-30 | $113.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$87.00K derived: sum of 2 quarters · filed 2019-11-08 | -$302.00K 10-Q · filed 2019-11-08 | -$426.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | -$200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$415.00K 10-Q · filed 2019-08-09 | -$539.00K derived: sum of 3 quarters · filed 2020-03-02 | -$792.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | -$215.00K 10-Q · filed 2019-05-10 | -$339.00K derived: sum of 2 quarters · filed 2020-03-02 | -$592.00K derived: sum of 3 quarters · filed 2020-03-02 | -$650.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | -$124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$377.00K derived: sum of 2 quarters · filed 2020-03-02 | -$435.00K derived: sum of 3 quarters · filed 2020-03-02 | -$600.00K 10-K · filed 2020-03-02 |
| 2017-09-30 | -$253.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$311.00K derived: sum of 2 quarters · filed 2018-11-09 | -$476.00K 10-Q · filed 2018-11-09 | -$692.00K derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | -$58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$223.00K 10-Q · filed 2018-08-09 | -$439.00K derived: sum of 3 quarters · filed 2019-03-15 | $2.06M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-03-31 | -$165.00K 10-Q · filed 2018-05-10 | -$381.00K derived: sum of 2 quarters · filed 2019-03-15 | $2.12M derived: sum of 3 quarters · filed 2019-03-15 | $2.09M derived: sum of 4 quarters · filed 2019-03-15 |
| 2016-12-31 | -$216.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $2.28M derived: sum of 2 quarters · filed 2019-03-15 | $2.25M derived: sum of 3 quarters · filed 2019-03-15 | $2.81M 10-K · filed 2019-03-15 |
| 2016-09-30 | $2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $2.47M derived: sum of 2 quarters · filed 2017-11-09 | $3.03M 10-Q · filed 2017-11-09 | $3.50M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-06-30 | -$29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $532.00K 10-Q · filed 2017-08-09 | $1.00M derived: sum of 3 quarters · filed 2018-03-15 | $1.24M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-03-31 | $561.00K 10-Q · filed 2017-05-10 | $1.03M derived: sum of 2 quarters · filed 2018-03-15 | $1.26M derived: sum of 3 quarters · filed 2018-03-15 | $1.38M derived: sum of 4 quarters · filed 2018-03-15 |
| 2015-12-31 | $468.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $704.00K derived: sum of 2 quarters · filed 2018-03-15 | $820.00K derived: sum of 3 quarters · filed 2018-03-15 | $1.04M 10-K · filed 2018-03-15 |
| 2015-09-30 | $236.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $352.00K derived: sum of 2 quarters · filed 2016-11-14 | $573.00K 10-Q · filed 2016-11-14 | $619.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $116.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $337.00K 10-Q · filed 2016-08-11 | $383.00K derived: sum of 3 quarters · filed 2017-03-16 | $354.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $221.00K 10-Q · filed 2016-05-13 | $267.00K derived: sum of 2 quarters · filed 2017-03-16 | $238.00K derived: sum of 3 quarters · filed 2017-03-16 | |
| 2014-12-31 | $46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $17.00K derived: sum of 2 quarters · filed 2017-03-16 | $24.00K 10-K · filed 2017-03-16 | |
| 2014-09-30 | -$29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | -$22.00K 10-Q · filed 2015-11-13 | ||
| 2014-06-30 | $7.00K 10-Q · filed 2015-08-13 | |||
| 2013-12-31 | $63.00K 10-K · filed 2016-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |